Literature DB >> 5225266

Studies on the longevity, sequestration and release of the leukocytes in chronic myelogenous leukemia.

P R Galbraith.   

Abstract

The intravascular life-span of leukocytes labelled in vitro with radioactive di-isopropylfluorophosphate was studied in 12 patients with chronic myelogenous leukemia (CML). In relapse, leukocyte specific activity (LSA) disappeared slowly; in remission, LSA curves approached normal and only a small proportion of LSA disappeared slowly. The level of maturation of the leukocytes that persisted in the blood was investigated by a leukocyte fractionation technique which excluded immature myeloid cells from leukocyte samples. The influence of extracorpuscular factors upon the pattern of disappearance of LSA was investigated by means of cross-transfusion experiments, and LSA curves obtained with in vitro and in vivo labelling were compared. The results suggest that: (1) the intravascular life-span of the mature leukemic neutrophil is prolonged in relapse and in remission; (2) intrinsically abnormal leukocytes are sequestered in an extravascular pool(s) but recycling occurs; (3) extracorpuscular factors modify the LSA curves; (4) exchange of leukocytes between intravascular and extravascular pools may not occur in relapse; and (5) the intravascular and extravascular pools constitute a self-sustaining pool(s) not replenished from a non-miscible precursor pool.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5225266      PMCID: PMC1935647     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  19 in total

1.  RED-CELL POOLING IN ENLARGED SPLEENS.

Authors:  P J TOGHILL
Journal:  Br J Haematol       Date:  1964-07       Impact factor: 6.998

2.  GRANULOCYTE KINETIC STUDIES IN PATIENTS WITH PROLIFERATIVE DISORDERS OF THE BONE MARROW.

Authors:  A M MAUER; T JARROLD
Journal:  Blood       Date:  1963-08       Impact factor: 22.113

3.  THE GRANULOCYTE RESPONSE TO ENDOTOXIN IN PATIENTS WITH HEMATOLOGIC DISORDERS.

Authors:  J C MARSH; S PERRY
Journal:  Blood       Date:  1964-05       Impact factor: 22.113

Review 4.  THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN.

Authors:  G E CARTWRIGHT; J W ATHENS; M M WINTROBE
Journal:  Blood       Date:  1964-12       Impact factor: 22.113

5.  PATTERNS OF GRANULOCYTE KINETICS IN HEALTH, INFECTION AND IN CARCINOMA.

Authors:  P R GALBRAITH; L S VALBERG; M BROWN
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

6.  STUDIES OF THE RETICULOENDOTHELIAL MASS AND SEQUESTERING FUNCTION OF RAT BONE MARROW.

Authors:  W R KEENE; J H JANDL
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

7.  MECHANISMS OF LEUKOCYTE PRODUCTION AND RELEASE. IV. FACTORS INFLUENCING LEUKOCYTE RELEASE FROM ISOLATED PERFUSED FEMORA OF RATS WITH CHLOROLEUKEMIA.

Authors:  E E VARSA; J LOBUE; E S HANDLER; B S DORNFEST; A S GORDON; F C MONETTE
Journal:  Acta Haematol       Date:  1965-05       Impact factor: 2.195

8.  Leukokinetic studies. XII. Kinetic studies of normal isologous neutrophilic granulocytes transfused into normal subjects.

Authors:  E Kauder; D R Boggs; J W Athens; H A Vodopick; G E Cartwright; M M Wintrobe
Journal:  Proc Soc Exp Biol Med       Date:  1965-12

9.  Return of leucocytes to the bone marrow in chronic myelogenous leukaemia.

Authors:  J H Moxley; S Perry; G H Weiss; M Zelen
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

10.  STROMAL CHANGES IN LEUKAEMIC AND RELATED BONE MARROW PROLIFERATIONS.

Authors:  N G SANERKIN
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

View more
  2 in total

1.  Studies on the exchange of leukocytes between blood and bone marrow in chronic myelogenous leukemia.

Authors:  G Chikkappa; P R Galbraith
Journal:  Can Med Assoc J       Date:  1967-07-08       Impact factor: 8.262

2.  Neutrophil alkaline phosphatase score in chronic granulocytic leukaemia: effects of splenectomy and antileukaemic drugs.

Authors:  A S Spiers; A Liew; A G Baikie
Journal:  J Clin Pathol       Date:  1975-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.